Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies

Chimeric antigen receptor (CAR) T cells directed against CD19 (CD19.CAR T cells) have yielded impressive clinical responses in the treatment of patients with lymphoid malignancies. However, resistance and/or relapse can limit treatment outcome. Risk of tumor escape can be reduced by combining treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wang, Sanmei (VerfasserIn) , Sellner, Leopold (VerfasserIn) , Wang, Lei (VerfasserIn) , Sauer, Tim (VerfasserIn) , Neuber, Brigitte (VerfasserIn) , Gong, Wenjie (VerfasserIn) , Stock, Sophia (VerfasserIn) , Ni, Ming (VerfasserIn) , Yao, Hao (VerfasserIn) , Kleist, Christian (VerfasserIn) , Schmitt, Anita (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Schmitt, Michael (VerfasserIn) , Schubert, Maria-Luisa (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 23, 2021
In: Oncology reports
Year: 2021, Jahrgang: 46, Pages: 1-12
ISSN:1021-335X
DOI:10.3892/or.2021.8121
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3892/or.2021.8121
Verlag, kostenfrei, Volltext: https://www.spandidos-publications.com/10.3892/or.2021.8121
Volltext
Verfasserangaben:Sanmei Wang, Leopold Sellner, Lei Wang, Tim Sauer, Brigitte Neuber, Wenjie Gong, Sophia Stock, Ming Ni, Hao Yao, Christian Kleist, Anita Schmitt, Carsten Müller‑Tidow, Michael Schmitt and Maria-Luisa Schubert

MARC

LEADER 00000caa a2200000 c 4500
001 1789536278
003 DE-627
005 20250930104517.0
007 cr uuu---uuuuu
008 220214s2021 xx |||||o 00| ||eng c
024 7 |a 10.3892/or.2021.8121  |2 doi 
035 |a (DE-627)1789536278 
035 |a (DE-599)KXP1789536278 
035 |a (OCoLC)1341441648 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wang, Sanmei  |d 1990-  |e VerfasserIn  |0 (DE-588)1191709442  |0 (DE-627)1670170527  |4 aut 
245 1 0 |a Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies  |c Sanmei Wang, Leopold Sellner, Lei Wang, Tim Sauer, Brigitte Neuber, Wenjie Gong, Sophia Stock, Ming Ni, Hao Yao, Christian Kleist, Anita Schmitt, Carsten Müller‑Tidow, Michael Schmitt and Maria-Luisa Schubert 
264 1 |c June 23, 2021 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Chimeric antigen receptor (CAR) T cells directed against CD19 (CD19.CAR T cells) have yielded impressive clinical responses in the treatment of patients with lymphoid malignancies. However, resistance and/or relapse can limit treatment outcome. Risk of tumor escape can be reduced by combining treatment strategies. Selective inhibitors of nuclear export (SINEs) directed against nuclear exportin‑1 (XPO1) have demonstrated anti‑tumor efficacy in several hematological malignancies. The aim of the present study was to evaluate the combination of CAR T cells with the SINE compounds eltanexor and selinexor. As expected, eltanexor and selinexor were toxic to CD19‑positive malignant cells and the sensitivity of cells towards SINEs correlated with the levels of XPO1‑expression in ALL cell lines. When SINEs and CAR T cells were simultaneously combined, SINEs exerted toxicity towards CAR T cells and impaired their function affecting cytotoxicity and cytokine release ability. Flow cytometry and western blot analysis revealed that eltanexor decreased the cytoplasmic concentration of the transcription factor phosphorylated‑STAT3 in CAR T cells. Due to CAR T‑cell toxicity, sequential use of SINEs and CAR T cells was evaluated: Cytotoxicity of CAR T cells increased significantly when target cells were pre‑treated with the SINE compound eltanexor. In addition, exhaustion of CAR T cells decreased when target cells were pre‑treated with eltanexor. In summary, whereas the concomitant use of SINEs and CAR T cells does not seem advisable, sequential use of SINEs and CAR T cells might improve the anti‑tumor efficacy of CAR T cells. 
700 1 |a Sellner, Leopold  |d 1984-  |e VerfasserIn  |0 (DE-588)143493825  |0 (DE-627)646576704  |0 (DE-576)337362963  |4 aut 
700 1 |a Wang, Lei  |d 1985-  |e VerfasserIn  |0 (DE-588)1076031994  |0 (DE-627)834093308  |0 (DE-576)444802398  |4 aut 
700 1 |a Sauer, Tim  |d 1981-  |e VerfasserIn  |0 (DE-588)138282013  |0 (DE-627)601099516  |0 (DE-576)307058166  |4 aut 
700 1 |a Neuber, Brigitte  |d 1974-  |e VerfasserIn  |0 (DE-588)1052913563  |0 (DE-627)789293188  |0 (DE-576)408653884  |4 aut 
700 1 |a Gong, Wenjie  |d 1989-  |e VerfasserIn  |0 (DE-588)1191709647  |0 (DE-627)1670171086  |4 aut 
700 1 |a Stock, Sophia  |e VerfasserIn  |0 (DE-588)1191523071  |0 (DE-627)1670143910  |4 aut 
700 1 |a Ni, Ming  |d 1989-  |e VerfasserIn  |0 (DE-588)1152978284  |0 (DE-627)1014346975  |0 (DE-576)499988280  |4 aut 
700 1 |a Yao, Hao  |d 1992-  |e VerfasserIn  |0 (DE-588)1286858801  |0 (DE-627)1843456370  |4 aut 
700 1 |a Kleist, Christian  |e VerfasserIn  |0 (DE-588)138977410  |0 (DE-627)703170287  |0 (DE-576)309272971  |4 aut 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
700 1 |a Schubert, Maria-Luisa  |d 1982-  |e VerfasserIn  |0 (DE-588)1147867631  |0 (DE-627)1007273801  |0 (DE-576)49608089X  |4 aut 
773 0 8 |i Enthalten in  |t Oncology reports  |d Athens : Nat. Hellenic Research Foundation, 1994  |g 46(2021), Artikel-ID 170, Seite 1-12  |w (DE-627)18263907X  |w (DE-600)1222484-4  |w (DE-576)049953168  |x 1021-335X  |7 nnas  |a Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies 
773 1 8 |g volume:46  |g year:2021  |g elocationid:170  |g pages:1-12  |g extent:12  |a Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies 
856 4 0 |u https://doi.org/10.3892/or.2021.8121  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.spandidos-publications.com/10.3892/or.2021.8121  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220214 
993 |a Article 
994 |a 2021 
998 |g 1147867631  |a Schubert, Maria-Luisa  |m 1147867631:Schubert, Maria-Luisa  |d 910000  |d 910100  |e 910000PS1147867631  |e 910100PS1147867631  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 13 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |d 50000  |e 910000PS141722495  |e 910100PS141722495  |e 50000PS141722495  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 11 
998 |g 138977410  |a Kleist, Christian  |m 138977410:Kleist, Christian  |d 910000  |d 911400  |e 910000PK138977410  |e 911400PK138977410  |k 0/910000/  |k 1/910000/911400/  |p 10 
998 |g 1286858801  |a Yao, Hao  |m 1286858801:Yao, Hao  |d 50000  |e 50000PY1286858801  |k 0/50000/  |p 9 
998 |g 1152978284  |a Ni, Ming  |m 1152978284:Ni, Ming  |p 8 
998 |g 1191523071  |a Stock, Sophia  |m 1191523071:Stock, Sophia  |p 7 
998 |g 1191709647  |a Gong, Wenjie  |m 1191709647:Gong, Wenjie  |p 6 
998 |g 1052913563  |a Neuber, Brigitte  |m 1052913563:Neuber, Brigitte  |d 910000  |d 910100  |e 910000PN1052913563  |e 910100PN1052913563  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 138282013  |a Sauer, Tim  |m 138282013:Sauer, Tim  |d 910000  |d 910100  |e 910000PS138282013  |e 910100PS138282013  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1076031994  |a Wang, Lei  |m 1076031994:Wang, Lei  |p 3 
998 |g 143493825  |a Sellner, Leopold  |m 143493825:Sellner, Leopold  |d 50000  |e 50000PS143493825  |k 0/50000/  |p 2 
998 |g 1191709442  |a Wang, Sanmei  |m 1191709442:Wang, Sanmei  |p 1  |x j 
999 |a KXP-PPN1789536278  |e 4056492204 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies","title_sort":"Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignancies"}],"origin":[{"dateIssuedDisp":"June 23, 2021","dateIssuedKey":"2021"}],"person":[{"family":"Wang","display":"Wang, Sanmei","role":"aut","given":"Sanmei"},{"family":"Sellner","display":"Sellner, Leopold","role":"aut","given":"Leopold"},{"family":"Wang","display":"Wang, Lei","given":"Lei","role":"aut"},{"display":"Sauer, Tim","family":"Sauer","role":"aut","given":"Tim"},{"display":"Neuber, Brigitte","family":"Neuber","role":"aut","given":"Brigitte"},{"display":"Gong, Wenjie","family":"Gong","given":"Wenjie","role":"aut"},{"display":"Stock, Sophia","family":"Stock","role":"aut","given":"Sophia"},{"family":"Ni","display":"Ni, Ming","role":"aut","given":"Ming"},{"role":"aut","given":"Hao","display":"Yao, Hao","family":"Yao"},{"given":"Christian","role":"aut","display":"Kleist, Christian","family":"Kleist"},{"given":"Anita","role":"aut","family":"Schmitt","display":"Schmitt, Anita"},{"display":"Müller-Tidow, Carsten","family":"Müller-Tidow","given":"Carsten","role":"aut"},{"display":"Schmitt, Michael","family":"Schmitt","role":"aut","given":"Michael"},{"display":"Schubert, Maria-Luisa","family":"Schubert","role":"aut","given":"Maria-Luisa"}],"id":{"doi":["10.3892/or.2021.8121"],"eki":["1789536278"]},"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["Sanmei Wang, Leopold Sellner, Lei Wang, Tim Sauer, Brigitte Neuber, Wenjie Gong, Sophia Stock, Ming Ni, Hao Yao, Christian Kleist, Anita Schmitt, Carsten Müller‑Tidow, Michael Schmitt and Maria-Luisa Schubert"]},"language":["eng"],"relHost":[{"id":{"eki":["18263907X"],"zdb":["1222484-4"],"issn":["1021-335X"]},"part":{"volume":"46","extent":"12","text":"46(2021), Artikel-ID 170, Seite 1-12","year":"2021","pages":"1-12"},"recId":"18263907X","language":["eng"],"type":{"bibl":"periodical"},"disp":"Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19‑positive malignanciesOncology reports","title":[{"title":"Oncology reports","subtitle":"an international journal devoted to fundamental and applied research in oncology","title_sort":"Oncology reports"}],"origin":[{"publisherPlace":"Athens","dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisher":"Nat. Hellenic Research Foundation"}],"pubHistory":["1.1994 -"]}],"recId":"1789536278"} 
SRT |a WANGSANMEICOMBININGS2320